News / Health

New Malaria Drugs Stop Parasite Early

Animal tests promising, but human trials still ahead

US scientists are experimenting with a compound of anti-malaria drugs that kill the parasite in its dormant liver stage.
US scientists are experimenting with a compound of anti-malaria drugs that kill the parasite in its dormant liver stage.

Multimedia

Audio
Art Chimes

U.S. medical researchers report a possible breakthrough that might prevent infection by one of the two most widespread varieties of malaria.

A new class of anti-malaria compounds kills the parasites in the developmental stages in the liver, before they get into the bloodstream.

The compounds proved highly successful in animal tests, according to a study published in Science, but their effectiveness in humans is still unproven.

Plasmodium vivax is the dominant strain of the malaria parasite outside Africa. Unlike the more deadly Plasmodium falciparum, vivax can infect a person but stay dormant in the liver for months or even years, before emerging to cause disease.

Scientists at the Scripps Research Institute in California and other institutions evaluated chemical compounds that were known to kill the malaria parasite in the blood. They were looking for ones that also might kill the parasite in its dormant liver stage.

In this study, the researchers mixed each one of the compounds with malaria parasites taken from live mosquitoes. Each combination was put with liver cells into individual compartments, called wells, on a microscope slide. Author Elizabeth Winzeler explains that to screen thousands of chemicals as potential malaria drugs required some sophisticated technology.

"We used an automated microscope to go and take about 100 images of each of the wells, and then we used computer scripts to analyze the images and identify those wells that had compounds that appeared to affect the development of the parasites."

To test potential drugs developed from the chemicals that looked promising, Winzeler and her colleagues infected laboratory mice with the malaria parasite. Left alone, the mice died within 10 days.  But "if you give the mice the same treatment, and you give them a small oral dose of the compounds that we made, the mice are cured or they never develop malaria in the first place."

These new substances, called IZPs, are effective in mice, Winzeler says, "but there's always a big step between going from something that works in a mouse model and actually going into something that's safe and efficacious in humans."

Researchers at Scripps, backed by the pharmaceutical company Novartis, are now considering that next step, safety testing in humans.

If successful, this work could lead to a malaria drug that attacks the dormant stage of the parasite, which occurs only in the Plasmodium vivax form of the disease. Scientists theorize that this period of dormancy was an evolutionary strategy to keep infection active through the cold winter months.

"For example, vivax malaria was found in places like Finland and England, up until about 100 years ago. And clearly, there weren't mosquitoes out biting people in December."

Vivax now occurs mainly in Asia and Latin America.

You May Like

UN: 1 Million Somalis at Risk of Hunger

Group warns region is in dire need of humanitarian aid, with at least 200,000 children under age of five acutely malnourished as drought hits southern, central part of nation More

Human Rights Groups Allege Supression of Freedoms in Thailand

Thailand’s military, police have suppressed release of independent report assessing human rights in kingdom during first 100 days of latest coup More

Jennifer Lawrence Contacts FBI After Nude Photos Hacked

'Silver Linings Playbook' actress' photos were posted on image-sharing forum 4chan; Federal Bureau of Investigations is looking into matter More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Ukraine Schools Resume Classes, Donate to Government Forcesi
X
September 02, 2014 12:58 PM
A new school year has started in Ukraine but thousands of children in the war-torn east are unable to attend because of ongoing clashes with pro-Russia rebels. In Ukraine's capital, patriotic education has become the norm along with donations to support injured security forces fighting to take back rebel-held areas. VOA's Daniel Schearf reports from Kyiv.
Video

Video Ukraine Schools Resume Classes, Donate to Government Forces

A new school year has started in Ukraine but thousands of children in the war-torn east are unable to attend because of ongoing clashes with pro-Russia rebels. In Ukraine's capital, patriotic education has become the norm along with donations to support injured security forces fighting to take back rebel-held areas. VOA's Daniel Schearf reports from Kyiv.
Video

Video US Detainees Want Negotiators for Freedom in North Korea

The three U.S. detainees held in North Korea were permitted to speak with foreign media Monday. The government of Kim Jong Un restricted the topics of the questions, and the interviews in Pyongyang were limited to five minutes. Each of the men asked Washington to send a representative to Pyongyang to secure his release. VOA’s Carolyn Presutti has our story.
Video

Video Internet, Technology Offer New Tools for Journalists

The Internet and rapidly evolving technology is quickly changing how people receive news and how journalists deliver it. There are now more ways to tell a story than ever before. One school in Los Angeles is teaching the next generation of journalists with the help of a state-of-the-art newsroom. Elizabeth Lee has this report.
Video

Video Turkmen From Amerli Describe Survival of IS Siege

Over the past few weeks, hundreds of Shi'ite Turkmen have fled the town of Amerli seeking refuge in the northern city of Kirkuk. Despite recent military gains after U.S. airstrikes that were coordinated with Iraqi and Kurdish forces, the situation remains dire for Amerli’s residents. Sebastian Meyer went to Kirkuk for VOA to speak to those who managed to escape.
Video

Video West Africa Ebola Vaccine Trials Possible by Early 2015

A U.S. health agency is speeding up clinical trials of a possible vaccine against the deadly Ebola virus that so far has killed more than 1,500 people in West Africa. If successful, the next step would be a larger trial in countries where the outbreak is occurring. VOA's Carol Pearson has more.
Video

Video Survivors Commemorate 70th Anniversary of Nazi Liquidation of Jewish Ghetto

When the German Nazi army occupied the Polish city of Lodz in 1939, it marked the beginning of a long nightmare for the Jewish community that once made up one third of the population. Roughly 200,000 people were forced into the Lodz Ghetto. Less than 7,000 survived. As VOA’s Kane Farabaugh reports, some survivors gathered at the Union League Club in Chicago on the 70th anniversary of the liquidation of the Lodz Ghetto to remember those who suffered at the hands of the Nazi regime.
Video

Video Cost to Raise Child in US Continues to Rise

The cost of raising a child in the United States continues to rise. In its latest annual report, the U.S. Department of Agriculture says middle income families with a child born in 2013 can expect to spend more than $240,000 before that child turns 18. And sending that child to college more than doubles that amount. VOA’s Deborah Block visited with a couple with one child in Alexandria, Virginia, to learn if the report reflects their lifestyle.
Video

Video Chaotic Afghan Vote Recount Threatens Nation’s Future

Afghanistan’s troubled presidential election continues to be rocked by turmoil as an audit of the ballots drags on. The U.N. says the recount will not be completed before September 10. Observers say repeated disputes and delays are threatening the orderly transfer of power and could have dangerous consequences. VOA correspondent Meredith Buel reports.

AppleAndroid